FindTrial
Sign In

Cognitive Dysfunction and Depression in Type 2 Diabetes Mellitus

Role of Metabolic and Neuroinflammatory Biomarkers in Cognitive Dysfunction and Depression in Type 2 Diabetes Mellitus - CDD in T2DM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067067
Enrollment
88
Registered
2024-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Haya Majid
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Chronic diabetes patients with more than 5 years of diagnosis and healthy volunteers

Exclusion criteria

Exclusion criteria: Individuals with significant co-morbidities. Pregnant or lactating individuals. Alcohol or any other drugs of abuse. History of recent viral infection, HIV, or hepatitis.

Design outcomes

Primary

MeasureTime frame
To study cognitive dysfunction and depression in patients with T2DM.Timepoint: Single Time point—

Secondary

MeasureTime frame
To assess metabolic biomarkers in patients with T2DM.Timepoint: Single Time point;To estimate neuroinflammatory biomarkers in patients with T2DM.Timepoint: Single Time point;To establish the association between metabolic and neuroinflammatory biomarkers in cognitive dysfunction, depression, and quality of life in patients with T2DM.Timepoint: Single Time point—

Countries

India

Contacts

Public ContactHaya Majid

Jamia Hamdard

nidhiagarwal@jamiahamdard.ac.in9818334770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026